He could stop kidney failure and dialysis in all of Egypt within two months and prevent seasonal influenza within three weeks.
Original statement
العوض من دلوقتي في اسبوع هيخفوا انا اعرف اعرف اوقف الفشل الكلوي في مصر كلها والغسيل الكلوي في شهرين في شهرين امنع وجود الانفلونزا الموسميه في ثلاث اسابيع امنع قو بس يا باشا عمم
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
He could stop kidney failure and dialysis in all of Egypt within two months and prevent seasonal influenza within three weeks.
Origin
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live! لايف منتظر (Open source)
- Published
- 8 February 2026
- Timestamp
- 0:24:41 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
- Attribution uncertainty
- Transcript is YouTube CC or machine-generated (no timestamps); wording may contain speech-recognition errors. Speaker attribution within live streams/podcasts is not marked in the transcript; the excerpt was judged to be Elawady's own speech from context. Recurrence = number of archive transcripts matching the keyword pattern ['الغسيل|غسيل', 'الكلي|الكلوي|كلوي'] (approximate; includes re-uploads/clips; 21 distinct text passages).
- Claimed mechanism
Not stated in this excerpt.
- Claimed health effect
Elimination of kidney failure, dialysis and seasonal influenza.
- Population concerned
Population of Egypt.
- Geographic restriction by Elawady
The claim is framed for Egypt ('in all of Egypt').
Diverging source versions
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live! النسيج البيني التعرق التبول ؟!! (Open source)
- Published
- 15 October 2025
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Further video in which the same statement recurs; no excerpt recorded. Archive transcript without timestamps.
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- الحلقة الرابعة من بودكاست #بدون_إثـــــــارة_جدل مع الدكتور ضياء العوضي (Open source)
- Published
- 14 December 2024
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Further video in which the same statement recurs; no excerpt recorded. Archive transcript without timestamps.
Scientific assessment
False – The statement contradicts the robust evidence.
Certainty of evidence: high – Further research is very unlikely to change the assessment.
1. What was claimed?
He says he knows how to stop kidney failure and dialysis in all of Egypt within two months and prevent seasonal influenza within three weeks, if his advice were generalised.
2. What is demonstrably correct?
Chronic kidney disease is described by the GBD authors as 'largely preventable and treatable' (I-INTB-12); prevention through control of diabetes and blood pressure and healthy lifestyle is a legitimate public-health goal. Diet changes can matter over years. In advanced CKD, a supervised very-low-protein diet probably delays kidney failure (165 fewer per 1000 reached end-stage kidney disease over 1-4 years; I-SRC-103).
3. What is wrong or exaggerated?
Elimination of kidney failure and dialysis in two months is not possible: 697.5 million people had CKD worldwide in 2017 and diabetic nephropathy caused almost a third of the burden (I-INTB-12); people on dialysis have lost most kidney function, and stopping dialysis is life-threatening. Seasonal influenza is a virus spread from person to person; it cannot be abolished in a country within three weeks by diet; vaccines reduce but do not eliminate it (RR 0.41) (I-INTB-13). He offers no data for either claim.
4. What remains unclear?
Egypt-specific CKD figures were not extracted from the GBD abstract.
5. Which studies support it?
None for the claim; I-SRC-103 shows that diet can delay (not reverse) kidney failure over years.
6. Which studies contradict it?
I-INTB-12, I-INTB-13, I-SRC-103, I-SRC-133, I-SRC-134.
7. What applies to Germany and Europe?
Not applicable; claim concerns Egypt.
8. What is known about Egypt?
Dialysis patients in Egypt depend on dialysis to survive; prevention of CKD requires long-term control of diabetes and high blood pressure. Influenza surveillance estimated about 16 million mild or moderate influenza illnesses and about 2660 deaths per season in Egypt in 2016-2019 (I-SRC-133).
9. What practical conclusion is appropriate?
Patients on dialysis must continue dialysis. Prevention of kidney disease is a long-term task.
Assessment details
- Rationale for certainty of evidence
The promise is incompatible with established kidney physiology: people on dialysis have lost most kidney function, and established kidney failure does not recover with diet. The best-tested dietary intervention, very-low-protein diets under supervision, only reduced progression to kidney failure over 1-4 years (RR 0.65; I-SRC-103), and the KDIGO 2024 guideline describes long-term, supervised management (I-SRC-134). Seasonal influenza causes millions of illnesses each season in Egypt (I-SRC-133) and is only reduced, not eliminated, by vaccination (I-INTB-13).
- Source quality
Machine transcript of a live stream; wording may contain recognition errors; meaning checked in context.
- Regional transferability
Framed for Egypt; the biology is universal.
- Individual exceptions
Acute kidney injury can recover; chronic kidney failure requiring dialysis generally does not.
- Regional scope of the claim
- refers to Egypt
- Last reviewed
- 26 October 2026 provisional
Scientific evidence in detail
Scientifically refuted – High-quality evidence shows the opposite, or the claim contradicts well-established physiology.
Research question: Can a dietary or lifestyle programme end established kidney failure and dialysis dependence within two months, or abolish seasonal influenza within three weeks, at population level?
Research question in detail (PICO)
- Population
- People with CKD/kidney failure on dialysis in Egypt; general population for influenza
- Intervention or exposure
- Elawady's dietary system applied nationally
- Comparison
- Standard nephrology care; usual influenza epidemiology and vaccination
- Geographic scope
- universal biology; Egypt-specific burden data
- Outcomes
- Recovery from dialysis dependence
- Progression to ESKD
- Seasonal influenza incidence
Study results as reported by the authors. Our assessment follows below.
What speaks for the claim?
Very low protein diets can delay dialysis in advanced kidney disease
Hahn D et al.. Cochrane Database Syst Rev 2020 · PMID 33118160 · DOI 10.1002/14651858.CD001892.pub5 Meta-analysisabstract checkednewly addedCochrane 2020: very low protein diets in advanced non-diabetic CKD.
- Actual result
- ESKD RR 0.65 (0.49-0.85); 165 fewer per 1000 over 12-50 months; low vs normal protein RR 1.05 (0.73-1.53).
- Methodological quality
- high (Cochrane; moderate-certainty evidence)
- Relevance
- indirect: shows diet can delay, not reverse, kidney failure over years
- Limitations
- Supervised diets; not his system; no reversal.
What speaks against the claim?
Global burden of chronic kidney disease
GBD Chronic Kidney Disease Collaboration. Lancet 2020 · PMID 32061315 · DOI 10.1016/S0140-6736(20)30045-3 Risk assessmentfull text, structured risk-of-bias assessmentGBD 2017 CKD burden.
- Actual result
- 697.5 million people with CKD in 2017; diabetic nephropathy almost a third of the burden.
- Methodological quality
- moderate (modelled)
- Relevance
- context
- Limitations
- Modelled estimates.
International kidney disease guideline 2024
KDIGO CKD Work Group. Kidney Int 2024 · PMID 38490803 · DOI 10.1016/j.kint.2023.10.018 Guideline / position statementabstract checkednewly addedKDIGO 2024 CKD guideline.
- Actual result
- Protein 0.8 g/kg/day (2C); very-low-protein diets only under close supervision in selected adults; SGLT2 inhibitors (1A); long-term risk-based management.
- Methodological quality
- guideline, GRADE
- Relevance
- direct for standard of care
- Limitations
- Selected recommendations read.
How much flu Egypt has each season
Fahim M et al.. Influenza Other Respir Viruses 2024 · PMID 39722214 · DOI 10.1111/irv.70061 Measurement / residue studyabstract checkednewly addedEgyptian influenza burden 2016-2019.
- Actual result
- About 16.4 million mild/moderate influenza illnesses and 2660 deaths per season (very wide CIs).
- Methodological quality
- moderate (surveillance model)
- Relevance
- direct for Egypt
- Limitations
- Wide uncertainty.
What does the overall evidence say?
Editorial assessment based on the studies above – not itself a study result.
Which position is better supported?
Kidney failure develops over years and established ESKD does not recover with diet; diet and drugs can delay progression. Influenza recurs each season and can be reduced but not abolished in weeks.
Why some studies weigh more
Cochrane evidence on the best-tested dietary intervention and the international guideline weigh most; burden data provide context. No evidence was offered for the claim.
Is a causal relationship established? Not applicable The claim is a promise without data; the evidence shows what diet can and cannot do.
Remaining uncertainty
Egyptian dialysis registry figures were not accessible in full text (Kidney360 'Global Dialysis Perspective: Egypt' had no abstract and no open full text).
Justified conclusion
Ending kidney failure and dialysis nationwide in two months is incompatible with kidney physiology; even the most effective dietary measure only delays ESKD over years. Abolishing seasonal flu in three weeks is not possible by any known means.
Does this depend on the country?
- General biological effects
- Irreversibility of end-stage kidney failure is universal.
- Eating habits
- Diet affects CKD progression slowly (protein, salt).
- Origin of the food
- Not applicable.
- Contaminants
- Not applicable.
- National production conditions
- Not applicable.
- Legal rules
- Dialysis provision is regulated nationally.
- Actual monitoring data
- Egyptian influenza surveillance (I-SRC-133) shows a large seasonal burden.
A regional difference that changes the conclusion is not supported by robust data.
Statistical re-check
- Implied control risk and NNT from RR and absolute difference – RR 0.65 with 165/1000 fewer implies control risk ~47% and NNT ~6 over 1-4 years; CI log-symmetric recalculated
Certainty of the overall evidence (GRADE, simplified)
- Main outcome
- Recovery from dialysis dependence or end of ESKD within months through diet
- Starting level
- high (randomised trials)
- Reasons for downgrading
- indirectness: no study tests the promise directly
- Result
- high
Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.
Clinical guidelines and official statements checked
- KDIGO: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD (2024) · Original publication
Suggests protein 0.8 g/kg/day in CKD G3-G5 (2C); very-low-protein diets with keto-analogues only under close supervision in selected adults at risk of kidney failure; sodium <2 g/day; SGLT2 inhibitors recommended (1A). - WHO: Influenza (seasonal) fact sheet (2025) · Original publication
About a billion cases and 3-5 million severe cases yearly; spreads easily via droplets, rapidly in crowded settings; vaccination is the best way to prevent influenza; yearly vaccination recommended.
Search strategy
Documented literature searches for this review (search strings in the original database syntax).
| Database | Date | Search | Looking for | Hits | Included |
|---|---|---|---|---|---|
| Europe PMC | 26 October 2026 | (dietary OR diet OR "low protein") AND "chronic kidney disease" AND (progression OR "kidney failure" OR dialysis) AND "Cochrane Database Syst Rev" | supporting evidence | 431 | |
| Europe PMC | 26 October 2026 | (diet OR "plant-based" OR "dietary pattern") AND ("chronic kidney disease" OR "kidney failure") AND (incidence OR progression) AND (meta-analysis) AND PUB_YEAR:[2018 TO 2026] | supporting evidence | 17188 | |
| Europe PMC | 26 October 2026 | (Egypt OR Egyptian) AND (hemodialysis OR haemodialysis OR "end-stage renal disease" OR "kidney failure") AND (prevalence OR incidence OR registry OR epidemiology) | contradicting evidence | 7177 | |
| PubMed | 26 October 2026 | Low protein diets for non-diabetic adults with chronic kidney disease[Title] AND Cochrane | supporting evidence | 2 | |
| PubMed | 26 October 2026 | (Egyptian renal registry) OR (Egypt[Title] AND (hemodialysis[Title] OR dialysis[Title]) AND (prevalence OR registry OR epidemiology)) | contradicting evidence | 45 | |
| PubMed | 26 October 2026 | influenza seasonal burden Egypt surveillance | contradicting evidence | 24 | |
| PubMed | 26 October 2026 | KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease | guidelines | 22 | |
| WHO / KDIGO websites | 26 October 2026 | WHO influenza (seasonal) fact sheet; KDIGO 2024 CKD guideline PDF | guidelines | 2 |
Open questions
Egyptian national dialysis registry data.
How deeply was this checked?
5 linked studies: 1 checked in full text (1 of them with a structured risk-of-bias assessment), 4 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.
Last scientific review: 26 October 2026
History of the verdict
- 25 October 2026 · Phase 1 · Initial assessment: False (moderate)
- 26 October 2026 · Phase 4 (systematic evidence review) · Verdict changed: False (moderate) → False (high)
Certainty raised from moderate to high: the promise is incompatible with established physiology (dialysis-dependent kidney failure is irreversible) and the best-tested dietary intervention (Cochrane, I-SRC-103) only delays ESKD over years; the current KDIGO guideline confirms long-term management. Verdict unchanged (“False”).
New sources: I-SRC-103 I-SRC-133 I-SRC-134
In plain language
Dr. Elawady said he could end kidney failure and dialysis in all of Egypt in two months and prevent seasonal flu in three weeks. There is no evidence for this. Kidney failure usually develops over years, often due to diabetes, and lost kidney function does not come back in two months. Flu is a virus that spreads between people; even vaccines only reduce it. People on dialysis must not stop it.
Studies on this claim
Studies supporting the claim (0)
No studies in this group.
Studies contradicting or limiting the claim (4)
-
Global burden of chronic kidney disease
GBD Chronic Kidney Disease Collaboration. Lancet 2020 · PMID 32061315 · DOI 10.1016/S0140-6736(20)30045-3Risk assessmentindependent cross-checkfull text, structured risk-of-bias assessmentAbout 9% of the world's population (698 million people) had CKD in 2017, about 7.1 million of them in Egypt; diabetes caused almost a third of the burden.
CKD is a widespread chronic disease, largely from diabetes.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Quantify CKD burden
- How was the study done?
GBD modelling
- How many people, animals or samples were studied?
195 countries
- What was actually found?
697.5 million cases, 1.2 million deaths
- How large was the observed effect?
prevalence 9.1%
- What do the results mean in everyday life?
Kidney disease is common and long-lasting; prevention takes years.
- What are the study's limitations?
Modelled estimates; many countries lack direct data; single-measurement definition may overestimate prevalence
- What does it say about Elawady's specific claim?
Contradicts stopping kidney failure in all of Egypt in two months.
- Do the results apply to Germany and Europe?
Moderate
- What can explicitly not be concluded from this study?
Does not give Egypt-specific numbers in the abstract.
-
Flu vaccines in healthy adults
Demicheli V et al.. Cochrane Database Syst Rev 2018 · PMID 29388196 · DOI 10.1002/14651858.CD001269.pub6Meta-analysisindependent cross-checkabstract checkedVaccination roughly halves confirmed influenza (2.3% to 0.9%); absolute benefit is modest.
No intervention eliminates seasonal influenza in weeks.
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Assess influenza vaccines
- How was the study done?
Cochrane review
- How many people, animals or samples were studied?
52 trials, >80,000 adults
- What was actually found?
Fewer influenza cases; small effect on hospitalisation
- How large was the observed effect?
RR 0.41
- What do the results mean in everyday life?
Flu shots reduce flu but do not abolish it; nothing removes seasonal flu from a country in three weeks.
- What are the study's limitations?
Old trials; abstract only
- What does it say about Elawady's specific claim?
Contradicts both the 3-week claim and blanket vaccine rejection, while showing modest absolute benefit.
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Does not address older or high-risk adults.
-
How much flu Egypt has each season
Fahim M et al.. Influenza Other Respir Viruses 2024 · PMID 39722214 · DOI 10.1111/irv.70061Measurement / residue studyindependent cross-checkabstract checkedEgypt has an estimated 16 million mild flu illnesses and thousands of flu deaths per season.
Millions of influenza illnesses per season in Egypt.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Estimate influenza burden in Egypt
- How was the study done?
Surveillance-based modelling
- How many people, animals or samples were studied?
8 sentinel hospitals, national extrapolation
- What was actually found?
Large burden, worst in elderly and small children
- How large was the observed effect?
About 16 million illnesses; 2660 deaths per season (wide CIs)
- What do the results mean in everyday life?
Flu is widespread every year
- What are the study's limitations?
Uncertain estimates
- What does it say about Elawady's specific claim?
Contradicts preventing flu in three weeks
- Do the results apply to Germany and Europe?
Indirect
- What can explicitly not be concluded from this study?
Effect of any diet on flu
-
International kidney disease guideline 2024
KDIGO CKD Work Group. Kidney Int 2024 · PMID 38490803 · DOI 10.1016/j.kint.2023.10.018Guideline / position statementindependent cross-checkabstract checkedRecommends supervised diet changes and kidney-protective drugs for chronic kidney disease.
Long-term supervised CKD care; no route to ending kidney failure in months.
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Guide CKD care
- How was the study done?
GRADE guideline
- How many people, animals or samples were studied?
not applicable
- What was actually found?
Protein about 0.8 g/kg/day; salt limits; SGLT2 inhibitors
- How large was the observed effect?
not applicable
- What do the results mean in everyday life?
Kidney disease care is long term and supervised
- What are the study's limitations?
Only parts read
- What does it say about Elawady's specific claim?
Contradicts quick cures
- Do the results apply to Germany and Europe?
High
No study in this group is marked as key.
Studies with mixed or unclear results (1)
-
Very low protein diets can delay dialysis in advanced kidney disease
Hahn D et al.. Cochrane Database Syst Rev 2020 · PMID 33118160 · DOI 10.1002/14651858.CD001892.pub5Meta-analysisindependent cross-checkabstract checked★ key studyUnder supervision, very low protein diets reduced the number reaching kidney failure over 1-4 years; ordinary low protein diets made little difference.
Diet can delay kidney failure over years in selected patients; it does not end kidney failure or dialysis within months.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Test protein restriction in chronic kidney disease
- How was the study done?
Cochrane review of trials
- How many people, animals or samples were studied?
17 trials, 2996 adults
- What was actually found?
Very low protein diets delayed kidney failure; low protein diets did not clearly
- How large was the observed effect?
ESKD RR 0.65 (0.49-0.85)
- What do the results mean in everyday life?
Diet can slow kidney disease, but slowly and under medical care
- What are the study's limitations?
Open-label trials; adherence difficult
- What does it say about Elawady's specific claim?
Contradicts reversal within two months
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Whether kidney failure can be reversed (it was not studied and did not occur)
No study in this group is marked as key.
Regional context
Germany / EU
Not applicable; claim concerns Egypt.
Egypt
Dialysis patients in Egypt depend on dialysis to survive; prevention of CKD requires long-term control of diabetes and high blood pressure. Influenza surveillance estimated about 16 million mild or moderate influenza illnesses and about 2660 deaths per season in Egypt in 2016-2019 (I-SRC-133).
What applies in my country?
General scientific assessment
False This claim is false: lost kidney function does not return through diet, the best dietary measures only delay kidney failure over years, and seasonal flu cannot be eliminated in weeks.
This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.
References
- Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.. GBD Chronic Kidney Disease Collaboration. Lancet 2020 · PMID 32061315 · DOI 10.1016/S0140-6736(20)30045-3
- Vaccines for preventing influenza in healthy adults.. Demicheli V et al.. Cochrane Database Syst Rev 2018 · PMID 29388196 · DOI 10.1002/14651858.CD001269.pub6
- The National Burden of Influenza-Associated Respiratory Illness Across Levels of Severity in Egypt, 2016-2019.. Fahim M et al.. Influenza Other Respir Viruses 2024 · PMID 39722214 · DOI 10.1111/irv.70061
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.. KDIGO CKD Work Group. Kidney Int 2024 · PMID 38490803 · DOI 10.1016/j.kint.2023.10.018
- Low protein diets for non-diabetic adults with chronic kidney disease.. Hahn D et al.. Cochrane Database Syst Rev 2020 · PMID 33118160 · DOI 10.1002/14651858.CD001892.pub5